ASKA Pharmaceutical Holdings Co.,Ltd. (TYO:4886)

TYO:4886 Revenue

ASKA Pharmaceutical Holdings had revenue of 18.24B JPY in the quarter ending September 30, 2026, with 14.50% growth. This brings the company's total for the last twelve months to 71.50B, up 6.68% year-over-year. In the fiscal year ending March 31, 2026, ASKA Pharmaceutical Holdings had annual revenue of 71.13B with 10.90% growth. That makes ASKA Pharmaceutical Holdings the 11,908th largest company in the world by revenue and 1,229th in Japan.

• Revenue (ttm): 71.50B
• Revenue Growth: +6.68%
• P/S Ratio: 0.86
• Revenue / Employee: 44.38M
• Employees: 1,611
• Market Cap: 61.45B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Pharmaceuticals Business 58.93B 82.8%
• Animal Health Business 7.33B 10.3%
• Overseas Business 4.64B 6.5%
• Other 306.00M 0.4%

Fiscal year ended Mar 31, 2026 See the full TYO:4886 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	71.13B	6.99B	10.90%
Mar 31, 2025	64.14B	1.30B	2.06%
Mar 31, 2024	62.84B	2.38B	3.94%
Mar 31, 2023	60.46B	3.85B	6.81%
Mar 31, 2022	56.61B	1.43B	2.58%

Data Source: S&P Global Market Intelligence Last updated: Nov 4, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 10, 2026

Data Sources Report a data error